Helmy Eltoukhy

This profile gathers the share dealings of Helmy Eltoukhy in Guardant Health, Inc., where the filings describe the role as chief executive. We count 38 filings; the first trade dates from 13 August 2021 and the latest from 1 October 2026.

Market trades split into 2 purchases (€5.3M) and 9 sales (€33.3M). On balance, insiders were net sellers of €28.0M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 4 share grants and 17 option exercises. So far in 2026, the count stands at no purchases and 7 sales.

The latest filing, published on 2 October 2026, reports an option exercise in Guardant Health, Inc. The last purchase on record was published on 16 March 2023, which is 1,312 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.